Pro Medicus Limited (ASX:PME) has released its Financial Report for the year ended 30 June 2026, covering the company’s international operations across Melbourne, Berlin, and San Diego, with financial statements prepared in accordance with the Corporations Act 2001 and Australian Accounting Standards.
Key Points
- Pro Medicus filed its Financial Report for the year ended 30 June 2026, covering operations in Melbourne, Berlin, and San Diego.
- EY conducted an independent audit of the Financial Statements and Remuneration Report, with the audit report contained on pages 91–95 of the annual report.
- As a Group 2 reporting entity, Pro Medicus will commence reporting under AASB S2 Climate-related Disclosures from 1 July 2026, with first disclosures to be included in the FY27 Annual Report.
- The report has been prepared with reference to the International Integrated Reporting Framework (IIRF).
Financial Report Scope and Preparation
The Financial Report covers Pro Medicus’ operations for the year ended 30 June 2026 and captures the company’s international presence across its headquarters in Melbourne, and offices in Berlin and San Diego. Financial statements have been prepared in accordance with the Corporations Act 2001 and Australian Accounting Standards, which the filing states ensures compliance with the International Financial Reporting Standards. The Directors’ Report has been integrated throughout the annual report and covers areas including corporate structure, principal activities, risk management, remuneration, and corporate governance, among other disclosures.
Independent Audit and Reporting Integrity
EY has conducted an independent audit of the Financial Statements and Remuneration Report contained within the annual report, with the audit report located on pages 91 to 95. According to the filing, Pro Medicus has an Audit and Risk Committee responsible for managing the process of verifying the integrity of periodic corporate reports released to the market. The reporting process includes confirmation from relevant business units or management on completeness and accuracy, followed by approval from Senior Executives, the CEO, and the Pro Medicus Board prior to external release.
Climate Disclosure Requirements Under AASB S2
Pro Medicus disclosed that it is preparing to meet mandatory climate-related financial disclosure requirements in Australia under AASB S2 Climate-related Disclosures. The company is classified as a Group 2 reporting entity and will commence reporting under the standard from 1 July 2026. The filing states that Pro Medicus will continue to develop its climate-related governance, risk management, and reporting processes ahead of these requirements, with the first climate-related financial disclosures to be included in the FY27 Annual Report. The company’s vision is stated as being the leading provider of best-in-class enterprise medical imaging software.
